Abstract:AIM: To investigate the effects of interferon-alpha (IFN-α) on the development of dendritic cells (DCs) derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia (CML). METHODS: Bone marrow mononuclear cells from 12 CML patients were cultured initially using cytokines as follows: recombined human granulocyte-macrophage colony stimulating factor (rhGM-CSF) plus IFN-α (IFN-α-DCs); rhGM-CSF plus recombined human interleukin-4 (rhIL-4) (IL-4-DCs); IFN-α alone; rhGM-CSF alone in 10% FBS RPMI-1640 medium for 7 days and then recombined human tumor necrosis factor-α (rhTNF-α) was added for another 3 days. The morphologic features were observed by Wright's staining under inverted microscope. CD_ 80,CD_ 86,CD_ 83,CD_ 1a and HLA-DR expression were assayed by flow cytometry. Cytogenetic analysis was performed for one CML patient by fluorescence in-situ hybridization (FISH), and the functions of antigen presenting were tested by mixed lymphocyte reaction (MLR). RESULTS: IFN-α-DCs displayed features in morphology that was similar to those of IL-4-DCs with delicate membrane projections. IFN-α-DCs showed an increase in expression of CD80, CD86, CD83, HLA-DR and more intense abilities of allogeneic antigen presentation with and without rhTNF-α stimulation, compared with the control groups of IL-4-DCs. FISH confirmed the DCs of both groups were leukemic origin. CONCLUSIONS: (1) IFN-α promoted the differentiation/activation of bone marrow mononuclear cells from patients with CML into activated dendritic cells. (2) The phenomenon of generation of activated DCs in vitro might contribute to therapeutic effect of IFN-α in CML. (3) IFN-α may be valuable for the generation of active bone marrow mononuclear cells-derived DCs to be as vaccination strategies of CML patients.

Effect of IFN-γ on B7-H1 expression of leukemia cell line U937

Effects of IFN-γ on Proliferation,Cell Cycle,Apoptosis and Invasion of Leukemia Cell Line FBL-3

Induction of dendritic cells with IFN-alpha and GM-CSF from bone marrow mononuclear cells from patients with chronic myeloid leukemia

Interferon-α in Combination with Homoharringtonine Induces K562 Cell Apoptosis Through Down-Regulating Human Telomerase Reverse Transcriptase Expression and Telomerase Activity

Effect of Interferon-Gamma on the Expression of Basic Fibroblast Growth Factor on Hep-2 Laryngeal Carcinoma Cell Lines

Modulate the Expression of B7.2 in B Cells of B Cell Chronic Lymphocytic Leukemia by Γ-Interferon

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

Effect of IFN-α on cell apoptosis and telomerase activity in K562 cells

Effect of IFN-γ on expression of VEGF-C and bFGF of laryngeal carcinoma cell lines

The Effects of IFN-α on Human Cutaneous T-cell Lymphoma Cell Line Hut78

[Influence of HLA Class I Molecules Expression on Tumor Cell Resistance to NK Lysis and the IFN-gamma Regulatory Effect].

The effects of HBV infection on the expression of interferon-γ

Effect of Interferon-Gamma on the Expression of Vascular Endothelial Growth Factor C on Hep-2 Laryngeal Carcinoma Cell Lines

The effect of IFNα- 2a on CD95 expression and apopotosis rate of peripheral blood cytotoxic T cells in hepatitis B patients

Effect of interferon on HEL cell apoptosis and JAK2 V617F mutation gene expression

Interferon-γ Augments Low-Density Lipoprotein Immune Complex Induced Matrix Metalloproteinase-1 Expression in U937 Cells

[Effects of Interferon-Γ on Biological Characteristics and Immunomodulatory Property of Human Umbilical Cord-Derived Mesenchymal Stem Cells].

Modulation of Gene Expression in MHCC97 Cells by Interferon Alpha

Opposing Effects of Interferon-Alpha and Interferon-Gamma on the Expression of Major Histocompatibility Complex Class I Chain-Related A in Tumors.

In vitro upregulation of B7 molecules expression by rhGM-CSF and rhIL-4 in myeloid leukemia cells

Influence of Over-Expression of the Pre-B Cell Leukemia Transcription Factor 1(PBX1) on the Expression of the SLE-susceptible Gene Encoding for the Inteferon-Inducible Nucleoprotein 16(IFI16)